GlassScriptPhysician profile
Vicente Gari
NPI 1942590104
$3,964.54
in general payments reported to CMS, 2019-2025
30 companies · $900 in 2025
The $900 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $578 · 2021: $390 · 2022: $714 · 2023: $509 · 2024: $175 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $940.94 | 2019-2025 | |
| Shield Therapeutics INC | $649.06 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $374.63 | 2021-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Boston Scientific Corporation | $343.31 | 2019-2020 | |
| Axonics, INC. | $213.88 | 2020-2023 | Axonics |
| Evofem Biosciences, INC. | $213.19 | 2022-2025 | Solosec, Phexx, Phexxi |
| Therapeuticsmd, INC. | $156.03 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $145.26 | 2022-2025 | |
| Vertical Pharmaceuticals, LLC | $132.76 | 2019-2020 | |
| Medical Device Business Services, INC. | $119.11 | 2022 | |
| Pfizer INC. | $88.41 | 2019-2023 | |
| Allergan, INC. | $58.65 | 2019-2020 | |
| Coopersurgical, INC. | $55.47 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $48.85 | 2023 | Seglentis |
| Exeltis, USA INC. | $45.30 | 2023-2025 | Slynd |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $43.67 | 2020-2021 | |
| Organon LLC | $41.94 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.48 | 2020-2021 | |
| Millicent US INC | $35.11 | 2020-2021 | |
| Coloplast Corp | $33.66 | 2019 | |
| Avion Pharmaceuticals | $32.92 | 2021-2023 | Balcoltra |
| Baxter Healthcare | $29.42 | 2019-2020 | |
| Daiichi Sankyo INC. | $19.88 | 2020 | |
| Becton, Dickinson and Company | $18.81 | 2022 | |
| Kci USA, INC. | $18.52 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Merck Sharp & Dohme LLC | $16.43 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.17 | 2021 | |
| Minerva Surgical, INC | $13.62 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.89 | 2019 | |
| Dysis Medical, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicente Gari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.